Inspire Medical Systems (INSP) filed an 8-K on November 3, 2025, primarily to furnish Q3 2025 financial results and investor presentation materials.
Q3 2025 Financial Performance: Revenue reached \(224.5 million, marking a 10% year-over-year increase. Gross Margin improved to 85.8%. GAAP Net Income was \)9.9 million, with Adjusted diluted EPS reported at \(0.38 (another summary noted Q3 EPS of \)0.34). Operating expenses rose 17%, driven by marketing and litigation costs (\(1.3M excluded from adjustments). The company completed \)50 million in share repurchases during the quarter. FY2024 revenu
...